Page 139 - Pharmacy Appeals 1/4/04 to 31/3/05

NHS Resolution Annual report and accounts 2021/22 115

Statement of cash flows for the

year ended 31 March 2022

Cash flows Notes 31 March 2022 Restated1
31 March 2021
£000 £000
Cash flows from operating activities

Net expenditure (43,284,831) 1,615,348
Other cash flow adjustments 2 886 982
(lncrease)/decrease in receivables 4 (1,789) 11,232

Increase/fdecrease) in payables 6 10,383 (46,279)
Increase/fdecrease) in provisions 7 43,307,723 (1,601,295)
Net cash inflow/(outflow) from operating activities 32,372 (20,012)

Cash flows from investing activities
Purchase of property, plant and equipment (43) (488)
Purchase of intangible assets (2,989) (164)

Net cash inflow/(outflow) from investing activities (3,032) (652)
Cash flows from financing activities
Net Parliamentary funding 221,500 197,802
Net financing 221,500 197,802

Net increase in cash and cash equivalents 250,840 177,138
Cash and cash equivalents at the beginning of the period 297,829 120,691
Cash and cash equivalents at the end of the period 5 548,669 297,829

The Notes on pages 118-1 56 form part of these financial statements.

The 2020/21 restatement is a decrease in the provision expense of £333 million to reflect a prior period adjustment for 2020/21
in respect of the revaluation of the known claims provision. See Note 7.4 for further details of the revaluation.